Lisata Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.

Top 25 shareholders own 25.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.2%	Erkki Ruoslahti	1,181,144	US$3.5m	0.85%	no data
3.42%	BML Capital Management, LLC	284,669	US$845.5k	0%	0.46%
2.22%	The Vanguard Group, Inc.	184,333	US$547.5k	1.45%	no data
1.26%	David Mazzo	104,651	US$310.8k	-40.1%	no data
1.22%	Renaissance Technologies LLC	101,622	US$301.8k	2.11%	no data
0.75%	Kristen Buck	62,672	US$186.1k	16%	no data
0.67%	BlackRock, Inc.	56,013	US$166.4k	0%	no data
0.61%	Geode Capital Management, LLC	50,898	US$151.2k	14.8%	no data
0.21%	Dimensional Fund Advisors LP	17,336	US$51.5k	48.2%	no data
0.17%	State Street Global Advisors, Inc.	14,348	US$42.6k	0%	no data
0.15%	Cook Wealth, LLC	12,175	US$36.2k	0%	0.02%
0.12%	HighTower Advisors, LLC	10,044	US$29.8k	0%	no data
0.12%	Merrill Lynch & Co. Inc., Banking Investments	9,658	US$28.7k	0%	no data
0.045%	UBS Asset Management AG	3,709	US$11.0k	371,000%	no data
0.042%	James Nisco	3,474	US$10.3k	85.3%	no data
0.032%	David Slack	2,642	US$7.8k	-87.2%	no data
0.031%	Morgan Stanley, Investment Banking and Brokerage Investments	2,542	US$7.5k	0%	no data
0.024%	Founders Capital Management Inc	2,000	US$5.9k	0%	no data
0.017%	Citigroup Inc.,Banking and Securities Investments	1,436	US$4.3k	0%	no data
0.012%	Castleview Partners, LLC	1,000	US$3.0k	0%	no data
0.0053%	Tower Research Capital Europe Limited	440	US$1.3k	-48.4%	no data
0.0052%	Steven Klosk	432	US$1.3k	-98.6%	no data
0.0033%	Gregory Brown	276	US$820.3	-99.1%	no data
0.00066%	Bank of America Corporation, Asset Management Arm	55	US$163.1	0%	no data
0.00047%	City National Rochdale, LLC	39	US$116.1	0%	no data